Zhitong Finance App News, Xintiandi (301277.SZ) announced that the company received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for etomide APIs approved and issued by the State Drug Administration. Etomidate is an imidazole derivative. It is a non-barbiturate intravenous anesthetic. It is a rapid hypnotic intravenous general anesthetic used to induce intravenous general anesthesia or to assist anesthesia, and is also used for short-term surgical anesthesia.

Zhitongcaijing · 01/07 07:57
Zhitong Finance App News, Xintiandi (301277.SZ) announced that the company received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for etomide APIs approved and issued by the State Drug Administration. Etomidate is an imidazole derivative. It is a non-barbiturate intravenous anesthetic. It is a rapid hypnotic intravenous general anesthetic used to induce intravenous general anesthesia or to assist anesthesia, and is also used for short-term surgical anesthesia.